DK0927043T3 - Sammensætninger til genoverförsel til det centrale nervesystem - Google Patents

Sammensætninger til genoverförsel til det centrale nervesystem

Info

Publication number
DK0927043T3
DK0927043T3 DK97920192T DK97920192T DK0927043T3 DK 0927043 T3 DK0927043 T3 DK 0927043T3 DK 97920192 T DK97920192 T DK 97920192T DK 97920192 T DK97920192 T DK 97920192T DK 0927043 T3 DK0927043 T3 DK 0927043T3
Authority
DK
Denmark
Prior art keywords
cells
compositions
nervous system
central nervous
gene transfer
Prior art date
Application number
DK97920192T
Other languages
English (en)
Inventor
Bruce Cherskey
Louis R Bucalo
Original Assignee
Univ New York Medical Ct
Titan Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York Medical Ct, Titan Pharmaceuticals Inc filed Critical Univ New York Medical Ct
Application granted granted Critical
Publication of DK0927043T3 publication Critical patent/DK0927043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK97920192T 1996-04-08 1997-04-07 Sammensætninger til genoverförsel til det centrale nervesystem DK0927043T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/629,308 US6210664B1 (en) 1996-04-08 1996-04-08 Method for gene transfer to the central nervous system
PCT/US1997/005746 WO1997037684A1 (en) 1996-04-08 1997-04-07 Method for gene transfer to the central nervous system

Publications (1)

Publication Number Publication Date
DK0927043T3 true DK0927043T3 (da) 2007-04-10

Family

ID=24522456

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920192T DK0927043T3 (da) 1996-04-08 1997-04-07 Sammensætninger til genoverförsel til det centrale nervesystem

Country Status (13)

Country Link
US (2) US6210664B1 (da)
EP (1) EP0927043B8 (da)
JP (2) JP2000508641A (da)
AT (1) ATE347903T1 (da)
AU (1) AU724537C (da)
CA (1) CA2251232C (da)
DE (1) DE69737101T2 (da)
DK (1) DK0927043T3 (da)
ES (1) ES2277356T3 (da)
PT (1) PT927043E (da)
TW (1) TWI222870B (da)
WO (1) WO1997037684A1 (da)
ZA (1) ZA972971B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system
CA2647246C (en) * 2006-03-30 2015-06-23 Research Foundation Of City University Of New York Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
MX2020012459A (es) 2018-05-24 2021-04-28 Celanese Eva Performance Polymers Llc Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE117375T1 (de) * 1987-09-11 1995-02-15 Whitehead Biomedical Inst Transduktionsveränderte fibroblasten und ihre anwendung.
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
DE69133205T2 (de) * 1990-10-19 2003-12-11 New York University, New York Eine methode zur transplantation von zellen in das gehirn und ihre therapeutische verwendung
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5529774A (en) * 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
AU3586993A (en) * 1992-01-23 1993-09-01 New York University A method for transplanting cells into the brain and therapeutic uses therefor
AU688321B2 (en) * 1993-04-21 1998-03-12 Institut Pasteur Biocompatible implant for the expression and secretion in vivo of a therapeutic compound
SG48813A1 (en) * 1993-08-12 1998-05-18 Cytotherapeutics Inc Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system

Also Published As

Publication number Publication date
CA2251232A1 (en) 1997-10-16
EP0927043A4 (en) 2004-09-01
WO1997037684A1 (en) 1997-10-16
ZA972971B (en) 1997-11-03
ATE347903T1 (de) 2007-01-15
JP2000508641A (ja) 2000-07-11
US20010003585A1 (en) 2001-06-14
JP2004337176A (ja) 2004-12-02
AU724537B2 (en) 2000-09-21
AU724537C (en) 2001-07-19
AU2444997A (en) 1997-10-29
CA2251232C (en) 2005-10-25
EP0927043B8 (en) 2007-04-18
PT927043E (pt) 2007-03-30
TWI222870B (en) 2004-11-01
EP0927043A1 (en) 1999-07-07
DE69737101D1 (de) 2007-01-25
HK1021801A1 (en) 2000-07-07
US6210664B1 (en) 2001-04-03
US6565845B2 (en) 2003-05-20
DE69737101T2 (de) 2007-05-31
EP0927043B1 (en) 2006-12-13
ES2277356T3 (es) 2007-07-01

Similar Documents

Publication Publication Date Title
Devine Mesenchymal stem cells: will they have a role in the clinic?
Kim et al. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease
Coffino et al. Immunoglobulin production: method for quantitatively detecting variant myeloma cells
EP1007630A4 (en) NATURAL KILLER CELL LINES AND METHOD FOR USE
SE0201328L (sv) Hematopoietisk differentiering av humana embryonala stamceller
DK0671923T3 (da) Leverreserveceller
CA2407505A1 (en) Hepatocyte lineage cells derived from pluripotent stem cells
ATE368103T1 (de) Isolierung, vermehrung und gezielte differenzierung von zäugetierstammzellen des zentralnervensystems
WO2002072762A3 (en) Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
CA2402299A1 (en) Serum free cultivation of primate embryonic stem cells
ATE399855T1 (de) Tierzellkulturmedium mit pflanzlichen nährstoffen
DK0728194T3 (da) In situ modifikation og manipulation af stamceller fra centralnervesystemet.
DE60020855D1 (de) Bedingte immortalisierung von zellen
Yoshida et al. Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells
DK0927043T3 (da) Sammensætninger til genoverförsel til det centrale nervesystem
Kim et al. Dedifferentiation of conditionally immortalized hepatocytes with long-term in vitro passage
Medina et al. Isolation of epithelial stem cells from dermis by a three‐dimensional culture system
Chan et al. Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells
ATE314461T1 (de) Vermehrte und genetisch modifizierte populationen menschlicher hämatopoitischer stammzellen
Racila et al. Are epidermal stem cells unique with respect to aging?
ATE311466T1 (de) Menschliche pancreas zellinien: entwicklungen und anwendungen
Jesnowski et al. Immortalized pancreatic duct cells in vitro and in vivo
Cossu et al. Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts.
Brack et al. ISSCR 2013: Back to Bean Town
Emmett Astroglial phenotype in vivo and in vitro.